Halozyme Therapeutics Inc Revenue per Employee (HALO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Halozyme Therapeutics Inc   (NASDAQ: HALO)
 

Halozyme Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 47.67% in the second quarter 2026, year on year to cumulative value of $1,664 million, Halozyme Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,933,187, this marks a new company high.
Within the Healthcare sector Employees of 12 other companies have achieved higher revenue per employee. While Halozyme Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 216 to 254. Halozyme Therapeutics Inc has 423 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HALO Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 47.67 % 42.23 % 51.6 % 22.12 % 40.79 %
Sales per Employee (TTM) $ 3,933,187 3,566,095 3,301,681 2,938,184 2,786,459
HALO's Total Ranking # 254 # 216 # 525 # 689 # 850
Seq. Revenue Change 27.68 % -16.61 % 27.52 % 8.76 % 22.98 %

HALO Company Profile >> Back to HALO Efficiency Comparisons >> Compare HALO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 13
Overall Market # 254

Revenue per Employee Statistics
High Average Low
$ 3,933,187 $ 981,859 $ 54,238
(Jun 30 2026)   (Sep 30 2012)



Financial Statements
Halozyme Therapeutics Inc 's Revenue MRQ $ 481 Millions Visit HALO's Income Statement
Halozyme Therapeutics Inc 's Revenues TTM $ 1,664 Millions Visit HALO's aggregate revenue growth
What are HALO's Sales? Visit HALO's Sales by Segment




Other Ratios
Halozyme Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
HALO's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for HALO's Competitors
Revenue per Employee for HALO's Suppliers
Revenue per Employee for HALO's Customers

You may also want to know
HALO's Sales Growth Rates HALO's Pe Price to earnings ratio HALO's Receivables Turnover Ratio HALO's Stock Quote
HALO's Net Income Growth Rates HALO's Ps Price to Sales ratio HALO's Sales per Employee HALO's Asset Turnover Ratio
HALO's Net Margin HALO's Pb Price to Book ratio HALO's Financial Strength Ratios HALO's Dividend Payout Ratio
Date modified: 2026-09-08T01:18:12+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.